Researchers invent a faster and more accurate test for diagnosing Zika

January 23, 2017
Credit: University of Texas Medical Branch at Galveston

Researchers from The University of Texas Medical Branch at Galveston, in conjunction with the New York State Department of Health's Wadsworth Center, have developed a new detection test for Zika that is faster and more accurate than currently available tests. The new test can detect Zika in a very small sample of blood in less than four hours. The new test is detailed in EBioMedicine.

One of the obstacles to stemming the tide of the recent Zika outbreak has been the lack of a rapid, accurate that can quickly determine whether someone has been infected with the Zika virus or not. While there is a laboratory test called PCR that can determine the presence of Zika in blood samples, it is only reliable within the first week after someone has begun showing symptoms of the disease.

There is another test that measures antibodies that the body produces in response to infection that can be used after the contracting virus has disappeared in patients, but it may mistake a different virus from the same viral group for Zika. This group, called flaviviruses, includes yellow fever, dengue fever, West Nile and Japanese encephalitis viruses.

"The new diagnostic test was designed to more accurately detect Zika for a longer period of time after infection and reduce false positives due to cross reactivity with other flaviviruses," said Pei Yong Shi, UTMB professor in the department of biochemistry and molecular biology. "The technology has been jointly patented by UTMB and the Wadsworth Center. We anticipate that the , called a microsphere immunofluorescence assay or MIA, will soon be approved for use in a clinical setting."

Using samples from 153 patients with known Zika and/or dengue virus, the researchers demonstrated that the MIA test is more sensitive than the currently available tests in diagnosing Zika infection.

Susan Wong, laboratory director for Wadsworth Center's Diagnostic Laboratory, contacted Shi to see if they could combine their efforts to develop a better Zika assay.

"Shi and I have successfully collaborated on various projects for more than a decade," said Wong. "Our areas of expertise compliment one another."

"Our partnership with the Wadworth's Center is an excellent example of innovation that allows us to combine unique areas of expertise to advance this diagnostic test," said Sundeep Mattamana, director of the UTMB Office of Technology Transfer. "Our office is working closely with the technology transfer office at the Wadsorth Center to protect and commercialize this joint technology."

Explore further: Zika virus: Five things to know

More information: Susan J. Wong et al. A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis, EBioMedicine (2017). DOI: 10.1016/j.ebiom.2017.01.008

Related Stories

Zika virus: Five things to know

February 8, 2016
A concise "Five things to know about.... Zika virus infection" article for physicians highlights key points about this newly emerged virus in CMAJ (Canadian Medical Association Journal)

US regulators issue emergency authorisation for Roche Zika test: company

August 29, 2016
Swiss pharmaceutical giant Roche said Monday that US regulators had issued emergency authorisation to use its not-yet-approved diagnostic test for detecting the Zika virus in certain circumstances.

CDC allocates $184 million for Zika protection

December 22, 2016
(HealthDay)—Nearly $184 million has been earmarked to protect Americans against Zika virus infection, the U.S. Centers for Disease Control and Prevention announced Thursday.

First widely available Zika test OK'd for emergency use

April 29, 2016
The first commercial test for the Zika virus has been cleared for emergency use in the U.S. and could be available by next week.

CDC sends Florida 950 kits to test for Zika virus antibodies

February 9, 2016
Federal health officials have sent the state of Florida an additional 950 kits to test for viral antibodies in people who have shown Zika symptoms after traveling to affected countries.

Recommended for you

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.